• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There isn't much information on how long-term exposure to these medications can affect the foetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus do not develop neurological conditions like impaired vision or hearing, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality studies are required.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication must evaluate the benefits of using it against the possible risks to the baby. Doctors don't have enough data to give clear advice, but can provide information on the risks and benefits to help pregnant women make an informed decision.

A study published in Molecular Psychiatry found that women who took ADHD medications in early pregnancy did not have an increased risk of fetal heart malformations or major birth defects that are structural. Researchers conducted a large, population-based case-control study to evaluate the incidence of major structural birth defects in babies born to mothers who had taken stimulants in the early stages of pregnancy, as well as those who had not. Pediatric cardiologists and clinical geneticists looked over the cases to ensure correct case classification and to minimize the chance of bias.

The study conducted by the researchers had some limitations. The researchers were not able in the beginning to distinguish the effects triggered by the medication from the disorder. This limitation makes it difficult to determine whether the small associations observed in the exposed groups are due to the use of medication or the confounding effect of comorbidities. The researchers did not examine long-term outcomes for offspring.

The study did show that babies whose mothers had taken ADHD medication during pregnancy were at slightly more risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or cut back on their medications prior to or during pregnancy. This was due to central nervous system-related disorders and the increased risk for admission was not found to be influenced by which stimulant medications were used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher likelihood of having to have an emergency caesarean section or having one whose baby scored low on the Apgar scale (less than 7). These increases did appear to be independent of the type of medication taken during pregnancy.

Researchers suggest that the minor risk of using ADHD medications during early pregnancies can be offset by greater benefits to both mother and baby from continuing treatment for the woman’s disorder. Physicians should discuss the issue with their patients and, if possible, assist them in developing strategies to improve coping skills that can lessen the effects of her disorder on her daily functioning and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and treated with medication, the issue of whether or not to end treatment during pregnancy is a question that more and more doctors confront. These decisions are often made without clear and reliable evidence. Instead, physicians must consider their own expertise and experience, as well as the experiences of other doctors and the research on the subject.

The issue of risk to the infant can be difficult to determine. A lot of studies on this subject are based on observational evidence instead of controlled research and their findings are often contradictory. In addition, most studies limit their analysis to live births, which may underestimate severe teratogenic effects that lead to abortion or termination of the pregnancy. The study that is discussed in this journal club addresses these shortcomings by examining data on both live and deceased births.

The conclusion: While some studies have found an association between ADHD medications and the possibility of certain birth defects, others have not found any evidence of a link and the majority of studies demonstrate a neutral or slightly negative impact. Therefore an accurate risk-benefit analysis must be done in each case.

For many women with ADHD who suffer from ADHD, the decision to stop taking medication is difficult if not impossible. In fact, in an article recently published in Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of isolation, and family conflict for these patients. Additionally, the loss of best medication for adhd and anxiety can affect the ability to complete job-related tasks and drive safely, which are important aspects of daily life for many people with adult adhd medication uk.

She recommends women who are unsure about whether to keep or stop taking medication because of their pregnancy, consider the possibility of educating friends, family members, and coworkers on the condition, its impact on daily functioning, and the benefits of keeping the current treatment regimen. In addition, educating them can make the woman feel more comfortable as she struggles with her decision. It is important to remember that certain drugs can pass through the placenta, so if the patient decides to discontinue her ADHD medication during pregnancy and breastfeeding, she should be aware that the effects of the drug could be passed on to the baby.

Risk of Birth Defects

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns about what impact the medications could have on fetuses. A study that was published in the journal Molecular Psychiatry adds to the body of information on this topic. Using two massive data sets researchers were able look at more than 4.3 million pregnancies and determine whether stimulant medication use increased the risk of birth defects. Researchers found that while the overall risk is low, first-trimester ADHD medication exposure was associated with slightly higher rates of specific heart defects like ventriculoseptal defect.

The researchers of the study did not find any association between early use of medication and other congenital anomalies, such as facial deformities or club feet. The results are in line with previous studies that have shown a small but significant increase in the risk of heart malformations in women who started taking ADHD medications prior to the birth of their child. The risk increased in the latter stages of pregnancy when many women decided to stop taking their medication.

Women who were taking adhd medication pregnancy (check out this one from Ddhszz) medication during the first trimester were more likely need a caesarean or have an insufficient Apgar after birth and had a baby that required breathing assistance at birth. However, the authors of the study were not able to eliminate selection bias by restricting the study to women who didn't have other medical issues that could have contributed to these findings.

The researchers hope that their research will aid in the clinical decisions of doctors who encounter pregnant women. The researchers suggest that while discussing benefits and risks are important, the choice on whether to continue or stop taking medication should be based on the severity of each woman's ADHD symptoms and her needs.

The authors also advise that, while stopping the medication is an option, it is not an option to consider due to the high rate of depression and other mental health problems in women who are pregnant or who are recently post-partum. Further, the research suggests that women who decide to stop taking their medications are more likely to experience a difficult time adjusting to life without them after the birth of their baby.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women with ADHD are often faced with a number of difficulties when they must manage their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to a new routine. Many women opt to continue taking their ADHD medication during pregnancy.

The risk for breastfeeding infant is minimal because the majority of stimulant medications passes through breast milk at a low level. The rate of medication exposure can vary depending upon the dosage and frequency of administration as well as time of day. In addition, individual medications enter the infant's system differently through the gastrointestinal tract and [Redirect-302] breast milk, and the effect of this on a newborn is not well understood.

Some physicians may discontinue stimulant medications during a woman's pregnancy due to the absence of research. This is a difficult choice for the patient, who must balance the benefit of continuing her medication against the possible dangers to the foetus. As long as more information is available, GPs can you get adhd medication without a diagnosis uk ask pregnant patients whether they have a background of ADHD or if they are planning to take medication in the perinatal stage.

A growing number of studies have shown that the majority of women are able to safely continue to take their ADHD medication during pregnancy and while breastfeeding. As a result, many patients are choosing to do so and in consultation with their physician, they have discovered that the benefits of keeping their current medication outweigh any risks.

Women with ADHD who are planning to breastfeed should seek the advice of an expert psychiatrist prior to becoming pregnant. They should review their medications with their prescriber and discuss the pros and cons of continued treatment, including non prescription adhd medication-pharmacological strategies. Psychoeducation should also be provided to help pregnant women suffering from ADHD recognize their symptoms and underlying disorder and learn about treatment options and reinforce existing strategies for managing. This should be a multidisciplinary effort including obstetricians, GPs, and psychiatrists. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and the child, as well as monitoring for indicators of deterioration, and, if necessary adjustments to the medication regime.